Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand
Key Highlights
- ➤Nanox.AI signs distribution agreement with Dosy Health for Thailand commercialization
- ➤HealthCCSng analyzes routine CT scans for coronary artery calcium measurements
- ➤Dosy Health cites preliminary hospital interest, with no purchase commitments
- ➤Commercialization remains subject to definitive agreements and regulatory requirements
Expert Statements
Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox
“Every routine CT scan can hold insights that may otherwise go unnoticed, and expanding our international presence is a key part of Nanox’s commercialization strategy”
Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox
“Our developing collaboration with Dosy Health offers an opportunity to introduce our Cardiac solution, to Thailand’s healthcare market. By combining our imaging analytics with Dosy’s local market knowledge and software-integration capabilities, we aim to help clinicians see what matters, and to build a foundation for future commercial opportunities.”
Sahatus Asawadilockchai, Chief Executive Officer of Dosy Health
“We’re seeing growing momentum for medical imaging AI in Thailand. The country has a large CT scanner base, with more scanners per capita than several Southeast Asian peers. For us, that’s a significant opportunity to unlock more clinical value from existing CT scans and better inform patient care.”
Sahatus Asawadilockchai, Chief Executive Officer of Dosy Health
“We are proud to collaborate with Nanox.AI, which brings deep expertise in medical imaging AI and has developed U.S. FDA-cleared software. At Dosy, we bring experience developing AI and integrating software for Thai hospitals, including those in one of the country’s largest private hospital groups. We have strong relationships with major hospitals, medical schools and public-sector organizations in Thailand. Together, we’ll start with cardiac imaging and focus on bringing AI findings into the systems Thai clinicians already use, with room to explore bone and liver imaging over time.”
Collaboration builds on Dosy Health’s established relationships with Mahidol University, Thammasat University and hospitals within the BDMS network, supporting planned distribution and commercialization in Thailand
PETACH TIKVA, Israel, [DATE] (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (NASDAQ: NNOX) (“Nanox” or the “Company”), a leader in innovative medical imaging technology, today announced that its subsidiary, Nanox AI Ltd. (“Nanox.AI”), is advancing a commercial collaboration with Dosy Health (“Dosy”), a Thailand-based healthcare technology company, to support the planned introduction and commercialization of Nanox.AI’s CT-based cardiac solution in Thailand.
Get started
Create a free account to read the full story.